These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3949487)

  • 1. Myeloproliferative disorders and nonmyelomatous paraprotein. A study of five patients and review of the literature.
    Berner Y; Berrebi A
    Isr J Med Sci; 1986 Feb; 22(2):109-12. PubMed ID: 3949487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraproteinemia in chronic lymphocytic leukemia].
    Jaworkowsky L; Puschkarew I; Jaworkowsky J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):1-12. PubMed ID: 58808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias.
    Dührsen U; Uppenkamp M; Meusers P; König E; Brittinger G
    Blut; 1988 Mar; 56(3):97-102. PubMed ID: 3355902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A plasmacytoma with changing paraproteinemia].
    Heilmann E; Schuckall A; Intorp H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(6):750-3. PubMed ID: 85587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bing-Neel syndrome. Polyneuropathy within the scope of paraproteinemia].
    Seitzer B; Spieker C; Schoon ML; Zidek W
    Fortschr Med; 1989 Apr; 107(13):291-3. PubMed ID: 2722107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preleukemia: hematological disorders prior to onset of leukemia.
    Takahashi I; Nakanishi T; Sakato J; Mikochi H; Kitajima K
    Acta Med Okayama; 1975 Dec; 29(6):437-44. PubMed ID: 132844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
    Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphoproliferative diseases with small molecular (monomere) IgM paraproteinemia (proceedings)].
    Spengler GA; Weber RM; von Wyttenbach H; Huser HJ
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1605. PubMed ID: 694500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metanephric adenoma of the kidney and chronic myeloproliferative syndrome. An unusual association].
    Monge Mirallas JM; Asensio Lahoz A; Martínez Bretones F; Acinas García O
    Actas Urol Esp; 1999 Apr; 23(4):359-62. PubMed ID: 10394657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy in chronic myeloproliferative disorders.
    Economopoulos T; Economidou J; Papageorgiou E; Dervenoulas J; Christodoulides C; Pappa V; Karakassis D; Terzoglou C; Athanassiadou S; Chalevelakis G
    Blut; 1989 Jan; 58(1):7-9. PubMed ID: 2917205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transitory oligoclonal paraproteinemia with virus infection and malignant lymphatic disease].
    Hermes C; Daus H; Köhler M; Mauch H; Scheurlen PG
    Dtsch Med Wochenschr; 1985 May; 110(21):837-40. PubMed ID: 2986934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metamorphosis of chronic myeloproliferative diseases].
    Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.